DK144261C - Medicinsk tablet indeholdende allopurinol - Google Patents

Medicinsk tablet indeholdende allopurinol Download PDF

Info

Publication number
DK144261C
DK144261C DK280174AA DK280174A DK144261C DK 144261 C DK144261 C DK 144261C DK 280174A A DK280174A A DK 280174AA DK 280174 A DK280174 A DK 280174A DK 144261 C DK144261 C DK 144261C
Authority
DK
Denmark
Prior art keywords
allopurinol
tablet
tablet according
weight
minutes
Prior art date
Application number
DK280174AA
Other languages
Danish (da)
English (en)
Other versions
DK144261B (de
Inventor
Harden David
John Torode Allan
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK144261B publication Critical patent/DK144261B/da
Application granted granted Critical
Publication of DK144261C publication Critical patent/DK144261C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK280174AA 1973-05-23 1974-05-22 Medicinsk tablet indeholdende allopurinol DK144261C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2462873A GB1460302A (en) 1973-05-23 1973-05-23 Tablet formulation
GB2462873 1973-05-23

Publications (2)

Publication Number Publication Date
DK144261B DK144261B (de) 1982-02-01
DK144261C true DK144261C (da) 1991-02-04

Family

ID=10214700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK280174AA DK144261C (da) 1973-05-23 1974-05-22 Medicinsk tablet indeholdende allopurinol

Country Status (21)

Country Link
JP (1) JPS577128B2 (de)
AT (1) AT351167B (de)
AU (1) AU469472B2 (de)
BE (1) BE815409A (de)
CA (1) CA977279A (de)
CY (1) CY941A (de)
DE (1) DE2424950A1 (de)
DK (1) DK144261C (de)
FI (1) FI156674A (de)
FR (1) FR2230341B1 (de)
GB (1) GB1460302A (de)
HK (1) HK1378A (de)
HU (1) HU170656B (de)
IE (1) IE39283B1 (de)
IL (1) IL44877A (de)
IT (1) IT8048966A0 (de)
KE (1) KE2808A (de)
MY (1) MY7800181A (de)
NL (1) NL190436C (de)
SE (1) SE402525C (de)
ZA (1) ZA743318B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1533243A (en) * 1975-02-13 1978-11-22 Wellcome Found Tablet formulation
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
DE3839825A1 (de) * 1988-11-25 1990-06-13 Henning Berlin Gmbh Feststoffdispersionen enthaltend oxipurinol und/oder seine alkali- oder erdalkalisalze
WO1996002234A1 (es) * 1994-07-18 1996-02-01 Luis Cipriano Carvajal Martin Granulos compactos altamente autodisgregantes para uso en formas galenicas conteniendo principios activos insolubles o poco solubles

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors
US3624205A (en) * 1967-04-25 1971-11-30 Burroughs Wellcome Co Treatment of hyperuricemia in humans

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors
US3497307A (en) * 1955-08-10 1970-02-24 Burroughs Wellcome Co Method of preventing oxidation of 6-substituted purines with 4-hydroxy-1h-pyrazolo(3,4-d)pyrimidine and 4,6 - dihydroxy-1h-pyrazolo(3,4-d)pyrimidine
US3624205A (en) * 1967-04-25 1971-11-30 Burroughs Wellcome Co Treatment of hyperuricemia in humans

Also Published As

Publication number Publication date
IT8048966A0 (it) 1980-06-13
JPS577128B2 (de) 1982-02-09
NL7406873A (de) 1974-11-26
FR2230341B1 (de) 1977-04-15
KE2808A (en) 1978-02-17
NL190436C (nl) 1994-03-01
HU170656B (de) 1977-07-28
JPS5040721A (de) 1975-04-14
CA977279A (en) 1975-11-04
SE402525C (sv) 1982-11-22
DE2424950A1 (de) 1974-12-19
IL44877A (en) 1976-11-30
FI156674A (de) 1974-11-24
HK1378A (en) 1978-01-13
CY941A (en) 1978-06-23
AU6925274A (en) 1975-11-27
FR2230341A1 (de) 1974-12-20
SE402525B (sv) 1978-07-10
DK144261B (de) 1982-02-01
IL44877A0 (en) 1974-07-31
IE39283B1 (en) 1978-09-13
MY7800181A (en) 1978-12-31
ZA743318B (en) 1975-05-28
AU469472B2 (en) 1976-02-12
AT351167B (de) 1979-07-10
NL190436B (nl) 1993-10-01
ATA426774A (de) 1978-12-15
GB1460302A (en) 1977-01-06
IE39283L (en) 1974-11-23
BE815409A (fr) 1974-11-22

Similar Documents

Publication Publication Date Title
KR960009182B1 (ko) 제약정제, 제약과립 및 그의 제조방법
DK175627B1 (da) Farmaceutisk præparat til oral indgift med reguleret afgivelse og forlænget virkning
NL8601961A (nl) Granulaire vorm van farmaceutisch werkzame stoffen met vertraagde afgifte.
DK144306B (da) Grundmasse til anvendelse ved fremstilling af en farmaceutisk enhedsdosis med langsom frigoerelse af en aktiv bestanddel samt fremgangsmaade til fremstilling deraf
NO174876B (no) Fremgangsmåte for fremstilling av et medikament i form av granuler basert på fenofibrat, innbefattende en inert kjerne
CZ20022429A3 (cs) Glyburidová kompozice
DK170793B1 (da) Dispergerbar lægemiddelformulering og fremgangsmåde til fremstilling heraf
AU2014360040A1 (en) Desmodium styracifolium (Osb.) Merr. flavonoids capsule, method of preparing same, and application thereof
NO175884B (no) Fremgangsmåte for fremstilling av en presset tablett som inneholder methylprednisolon og et super-desintegrasjonsmiddel
Alhalmi et al. Sustained release matrix system: an overview
WO2006115770A2 (en) Orally disintegrating pharmaceutical tablet formulations of olanzapine
JP4636796B2 (ja) ルミラコキシブ含有医薬組成物
NO157805B (no) Fremgangsmaate for fremstilling av et preparat for behandling av urinveisinfeksjoner.
CN108201529B (zh) 一种含有尿酸转运蛋白抑制剂的药物组合物及其制备方法
DK144261C (da) Medicinsk tablet indeholdende allopurinol
CN100490797C (zh) 药物组合物
CN102499923A (zh) 一种药物组合物、其制备方法及用途
AU2002213900A1 (en) Pharmaceutical compositions
FR2529784A1 (fr) Medicament a liberation retardee contenant du 1-(p-(isopropylthio)-phenyl)-2-octylamino-1-propanol
CN101677981A (zh) 药物制剂
NL8402128A (nl) Werkwijze ter bereiding van een preparaat van indomethacine of niomethacine met retard-werking.
NO774400L (no) Fremgangsmaate til fremstilling av farmasoeytiske sammensetninger
CN101219122A (zh) 盐酸吡格列酮分散片及其制备方法
IE51157B1 (en) Sustained release theophylline tablet having reduced bulk
JP4845087B2 (ja) 経口投与用製剤

Legal Events

Date Code Title Description
PUP Patent expired